Five years after participating in an allogenic CAR-T cell therapy trial, a multiple myeloma patient has remained disease-free. After being diagnosed with multiple myeloma in 2018, a 63-year-old patient underwent multiple years of standard-of-care therapy at Cleveland Clinic. Despite experiencing…
Author: Elizabeth Gregerson
HHS has appointed Harvey Risch, MD, PhD, as chairman of the President’s Cancer Panel. Dr. Risch is professor emeritus and senior research scientist in epidemiology at New Haven, Conn.-based Yale School of Public Health and Yale School of Medicine, according…
San Francisco-based UCSF Health and Fremont, Calif.-based Washington Health have opened the UCSF-Washington Cancer Center, also in Fremont. The organizations held a ribbon-cutting ceremony and open house Dec. 11, the Tri-City Voice reported Dec. 16. The cancer center houses 17…
A drug screening platform designed by researchers at Memphis, Tenn.-based St. Jude Children’s Research Hospital can rapidly identify new and effective drug combinations for cancer and other diseases, according to a study published Dec. 15 in Nature Communications. The platform,…
The Smilow Cancer Hospital at Greenwich (Conn.) Hospital will receive $25 million from an anonymous donor in honor of retired oncologist Dickerman Hollister, MD. The gift will be used toward the renovation and expansion of cancer care facilities within Greenwich…
Advertisement
Orange, Calif.-based UCI Health has added the Cancer & Blood Specialty Clinic as an affiliate to its physician network. The partnership will streamline UCI Health’s tertiary and quaternary cancer care services with Cancer & Blood Specialty Clinic’s oncology and hematology…
Oncology and radiology leaders have called into question a study led by researchers at Oakland-based University of California that found personalized risk-based breast cancer screening as effective as standard annual screening guidelines. The study, published Dec. 12 in JAMA Network,…
An investigational breast cancer vaccine produced an immune response in 74% of clinical trial participants, according to data being presented at the San Antonio Breast Cancer Symposium. Cleveland Clinic researchers conducted the phase 1 clinical trial, which enrolled 35 patients…
Patients with oropharyngeal cancer who were treated with proton therapy experienced a 91% five-year overall survival rate, compared to 81% for those who received photon therapy, according to a study published Dec. 11 in the Lancet. Eighteen health systems participated…
University of Miami Sylvester Comprehensive Cancer Center has named Tracy Crane, PhD, as the Brigitte Burke Endowed Chair for Women’s Cancer Research. Dr. Crane serves as co-leader of the center’s Cancer Control Program and its director of lifestyle medicine, prevention…